Literature reviews  >  Articles for review > Wiggins et al. Application of a novel human cervical... 

 

About SDI
Mission
Diagnostic
Priorities
Workplan
Activities
Newsletters
Grants
Publications
Journal articles
Guidelines
Manuals
Reports
Literature reviews
Contact us

Assessment of mucinase activity in patients with and without bacterial vaginosis showed no significant differences between clinical groups.

Application of a novel human cervical mucin-based assay demonstrates the absence of increased mucinase activity in bacterial vaginosis.
Wiggins R, Millar MR, Soothill PW, Hicks SJ, Corfield AP.
Inter J STD AIDS. 2002;13:755-760

 

Summary:

Question
How well does a novel ELISA mucinase assay compare to assays for enzyme activities already identified as markers for bacterial vaginosis?

Design
This study describes a blinded comparison of the results of ELISA assays for mucinase and other enzyme activities with those of Gram stain scoring performed on vaginal swabs for the diagnosis of bacterial vaginosis.

Participants
One hundred pregnant women <14 weeks gestational age attending for consultation concerning surgical termination of pregnancy who had not had antibiotic treatment in the previous 4 weeks were tested. The age range was between 16 and 45 years with a mean of 28.8 years. Eight women were excluded from the analyses due to poor quality of the Gram-stained slide.

Description of Tests and Diagnostic Standard
Two high vaginal swabs were collected from each woman during a speculum examination. One swab was placed in 2.5 mL of buffer, vortexed for 15 minutes, stored at 4oC, and tested for enzymatic activity within 24 hr. The mucinase assay measures the activity of a group of glycosidases and proteinases capable of degrading human cervical mucin. The substrate for the assay was made by pooling cervical mucus from 60 patients that were negative for sexually transmitted diseases and bacterial vaginosis. The mucus was purified, labeled with biotin in either the protein or carbohydrate moieties, and bound to wells of ELISA plates. After addition of the vaginal swab sample eluent to the test wells, and incubation at 37oC for 1 hour, the mucinase activity (i.e. cleavage of the biotin labeled protein or carbohydrate moiety from the bound mucin) of each sample was measured by a colorimetric biotin detection reaction. Mucinase activity was calculated as the difference between the OD of the blank well and the OD of the sample. Previously developed ELISA assays for sialidase, ß-D-N-acetylgalactosamine, ß-D-N-acetylglucosamine, and proteinase were also performed.

The second vaginal swab was rolled onto a glass slide and Gram-stained for the diagnosis of bacterial vaginosis. The vaginal flora was graded as Grade 1 (predominantly lactobacilli), Grade 2 (mixed lactobacilli and BV flora), or Grade 3 (BV flora) according to a modified Spiegel's criteria.

Main Outcome Measures
The mucinase ELISA assay was optimized and the mucinase activity, sialidase, ß-D-N-acetylgalactosamine, ß-D-N-acetylglucosamine, and proteinase activities for each clinical group determined by the Gram stain score were compared.

Main Results
The enzymatic activities of the 92 vaginal fluid samples by grade of bacterial vaginosis are shown in the table.

Enzymatic activity in vaginal swab fluid by grade of bacterial vaginosis determined by Gram stain among 92 pregnant women
Assay Enzyme activity* by Gram stain result Statistical significance
Group 1
BV negative (n=46)
Group 2
Mixed flora (n=22)
Group 3
BV positive (n=24)
P
1 vs 3
P
1 vs 2
P
2 vs 3

Mucinase 

           

Protein
pH 4.2

0.219 0.102 0.175 NS NS NS
Protein
pH 5.5
0.212 0.078 0.084 NS NS NS
Carbohydrate
pH 4.2
0.410 0.261 0.221 NS NS NS
Carbohydrate
pH 5.5
0.379 0.439 0.083 NS NS NS

Sialidase**

           
AGP 0.000 1.358 2.685 .0001 .03 .004
BSM 2.427 4.142 7.928 .0001 .02 .001
ß-galactosidase 0.000 0.080 0.300 .0008 NS NS

ß-N-acetyl-
hexosaminidase

0.120 0.200 0.230 .049 NS NS
Proteinse 0.065 0.060 0.000 NS NS NS

*Enzyme activity is optical density/mL fluid/h except for sialidase, which is nmole sialic acid released/mL fluid/h
**Sialidase assay substrates were human alpha-1-acid glycoprotein (AGP) and bovine submaxillary mucin (BSM)

Authors' Conclusions
No differences in mucinase activities were detected between normal and BV groups, while significant elevation of sialidase and other glycosidases was confirmed as reported before. Mucinase activity is a normal event in the mucus barrier.

Source of funding: Tommy's Campaign, Kennington Rd, London SW

For correspondence: Anthony Corfield, University Division of Medicine, Bristol Royal Infirmary, Bristol BS2 8HW, UK. E-mail address: tony.corfield@bristol.ac.uk.

 

   

about SDI | newsletters | grants | publications | literature reviews

WHO Home - WHO Search - TDR Home - SDI Home - SDI Contact us
(c) WHO/OMS 2001